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SUMMARY. Methods of i dent if i cat i on of des loratad ine in med i c ines by absorpt i on spectrophotom etry and TLC have been 
developed.
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Introduction. The current pharmaceuti cal 
analys is has got more emphas is to sati sfy o u r query for 
better understanding o f p hys i cochemi cal propert ies o f 
p harmaceuti cal compounds, by the use of advanced 
instrumental methods. It also plays an important part 
for qual ity assurance of pharmaceuti cal product 
throughout the shelf l ife. The pharmaceuti cal industry 
i s under increased scrut iny to constra i n costs a nd yet 
consistently del iver to market safe, e fficac ious products 
that fulfi ll med ical needs. As a part o f t h is, drug a n alys is 
also plays an i mportant role. Standard analyti cal 
procedure for newer drugs or formati on may not be 
ava ilable in Pharmacopoe i a; it is essenti al to develop 
new analyti cal methods wh i ch are accurate, prec ise, 
specific, linear, s imple and rap id. Desloratadi ne 
(8-chloro-6,11-d i hydro-11 -(4-p iperdinyl idene)-5H- 
benzo[5,6]cyclohepta[1,2-b]pyri dine) is a med i c i ne 
used to treat allergies. It is marketed under several 
trade names such a s N eoClarityn, Claramax, Clari nex, 
Edem, Lar inex, Aeri us, Dazit, Azomyr, Deselex and 
Delot. It is an active metabol ite of loratadine (second 
generati on), wh ich is also on the pharmaceuti cal 
market. Desloratadine is a tricycl i c a nti h istam ine (t h ird 
generation), wh i ch has a selective and peri pheral 
H1-antagon i st act i on. It is an antagon ist at h istam ine 
H1 receptors, and an antagon i st at all subtypes of the 
muscari n ic acetylchol i ne receptors. Desloratadine is a 
non-sedating, long-acting histam ine antagonist with 
selective peri pheral H1-receptor antagon ist activity. 
After oral adm inistrati on, desloratadi ne selectively 
blocks peripheral histam ine H1-receptors, because the 
substance is e xcluded from e ntry to the central nervous 
system. It has a long-lasting effect and in moderate 
and low doses, does not cause drows iness because it 
does not read ily enter the central nervous system. 
Unl ike other anti h i stam ines, desloratadine is also 
effective in rel ieving nasal congestion, parti cularly in 
pati ents with allerg ic rh i n iti s. Analys is o f d e s loratad ine 
is not descr ibed in Pharmacope i a, that’s why develop­
ment and val idati on of methods for determ inati on of 
desloratadine in med i c ines was our ma i n a im [1]. We 
proposed and developed a method for spectrophoto- 
metri c a nd chromatograph i c identifi cati on o f d e s lora­
tadine in med i c i nes.
The aim of our study was to develop methods 
to identify desloratadine in med ic ines by methods
absorpti on spectrophotometry and th in layer chro­
matography.
Materials and methods of research. The
objects o f the study were tablets tablets «Aeri us», tablets 
«Deslor», tablets «Aeriallerg», Pharmacopoe ial stan­
dard sample SPU desloratadine (certificate number 
11/1-3187 of 08/13/14), purchased by the State 
Enterpri se «Ukra i n i an Research Pharmacopoei al 
Center Qual ity of drugs.”
Analytical equipment: UV spectrophotometer 
Lambda 25, Scales AVT-120-5D, measuri ng vessel 
glass and reagents that meet the SPU requ irements. 
TLC test was carri ed out us ing S i l i ca gel, chromato­
graph i c plates 60 F254 «Merck» (Germany) and 
«Sorbf l» (Russ a).
In develop ing the techn i que o f identifi cati on data 
as part of de s loratadine med i c i nes was chosen by UV- 
spectrophotometry a nd TLC.
Results and discussion. We had previously 
stud i ed the behavi or o f d e s loratadine in the UV spectra 
us ing in different solvents (ethanol, water R, 0.1 mol/l 
soluti on of hydrochlori c ac i d). The behavior of 
desloratadine in the UV spectrum in different solvents 
showed that all drugs have character i st i c absorpti on 
bands i n the wavelength range (220-360 nm). 
Absorpti on maxi mum of desloratadine: in ethanol -  
when 244±2 nm; 0.1 M soluti on of hydrochlori c ac i d 
at 280±2 nm; in water -  at 244±2 nm and 273±2 nm 
(fig. 1). It makes it poss ible for the use of UV-spectro- 
photometry for analys i s of desloratadi ne in med i - 
c i nes [2].
We had i nvestigated various mob i le phases 
(solvent system) in order to identify the o pti mal cho ice 
of desloratadine investi gat ion by TLC in med ic ines. The 
factors of mob i l ity in the stud ied systems of deslora­
tadine solvents, are l isted in table 1, 2.
In order to develop methods of identifi cati on of 
desloratadine in d ifferent solvent system, we investi - 
gated the sens itivity of detecti on desloratadine. The 
value detection l i m it desloratadine and selection of 
opti mal developers us ing different mob ile phases are 
g iven i n table 1-2. We found that desloratadi ne 
identifi cati on by TLC us ing a sens itive of all investi - 
gated solvents. Therefore, to i dentify a part deslorata­
dine tablets can be used TLC method. Establ i shed that 
the most opti mal Rf observed us ing rmob i le phases:
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dіoxane-benzene-ammon і а (25 %) (7: 12: 1) and However, the express solvent system n-butanol-aceti c
n-butanol-acet і c ac і d-water (1: 1: 1). The detect ion ac і d-water (1: 1: 1) yi elds a solvent system d ioxane-
limit desloratad іпє іп these systems і s 0.2-0.4 mg. benzene-ammon і a (25 %) (7: 12: 1).
F i gure 1. Electron ic a bsorpt i on spectra for: 1 -  solut i on from tablets «D e s lor« (in 0.1 mol/l solut i on of h ydrochlori c ac i d), 2 -  
solut i on from tablets «Deslor« (in ethanol), 3 -  solut i on from tablets «Deslor« (in water R), 4 -  solut i on Pharmacopoe i al 
standard sample S PU of d e s loratad ine (in et hanol).
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Table 1. Chromatograph і с characteri st і cs ot d es loratad ine in d ifferent solvent systems
M obile phase
Stationary phase (plate) 
R f  on «M erch»
The lim it o f  detection, 
m icrogram s
chloroform -acetone (8 : 2) 0.05 0.4
n-butanol-m ethanol (3 : 2) 0.18 0.2
chloroform -m ethanol (9 : 1) 0.24 0.4
m ethanol-am m onia (25 %) (100 : 1.5) 0.28 0.4
dioxane-benzene-am m onia (25 %) (7 : 12 : 1) 0.42 0.4
toluene-acetone-ethanol,-am m onia (25 %) (45 : 45: 7.5 : 2.5) 0.20 0.4
ethylacetate-m ethanol-am m onia (25 %) (85 : 10 : 5) 0.13 0.6
n-butanol-acetic acid-w ater (1 : 1 : 1) 0.48 0.2
ethanol-acetic acid-w ater (5 : 3 : 2) 0.36 0.4
Table 2. Chromatograph i c characterist i cs of d e s loratadi ne i n different solvent systems w ith different developers
Substance Rf
M o b i le  p h a s e




(1 : 1 : 1)
D ioxane- 
benzene- 
am m onia (25 %) 









































desloratadine 0,48 0,42 yellow - - light orange orange
blue-
green
Thus, identificati on o f d e s loratadine med ic ines we 
offer TLC-method us i ng solvent system d i oxane- 
benzene-ammon i a (25 %) (7 : 12 : 1) and stati onary 
phase -  plate «Merch».
The a n alys is cons i dered probable, though the test 
requ i rements «Check suitabi l ity chromatograph ic 
system».
Checking the suitability o f the chromatographic 
system. Chromatograph ic system is considered 
appropr ate when:
-  The chromatogram obta i ned with reference 
solut ion i s a clearly v i s ible spot;
-  Rf pri nc i pal spot in the chromatogram o bta i ned 
with reference solution to be about 0.6.
Investigation solutions from tablets «Aerius», tablets 
«Deslor», tablets «Aeriallerg». To sample powder tablets 
or powder, equ ivalent to 0.01 g desloratadine, add 
5.0 ml of ethanol R and d ilute with ethanol R to 10.0 ml, 
m ix and fi lter.
Reference solution. 0.01 g Pharmacopoeialstandard 
sample SPU of desloratadine dissolved in ethanolR and 
d i lute with the same solvent to 10.0 ml.
Mob ile phase: di oxane-benzene-ammonia (25 %) 
(7 : 12 : 1).
Samples that are a pplied: 50 mg, a ppl ied the test 
soluti on a nd investi gati on solut ions.
Over a path o f  10 cm from the starting line.
Developer: Dragendorff reagent.
Results: the chromatogram o bta i ned with the test 
soluti on is detected at the ma i n spot spots bas i c
substance i n the chromatogram obta i ned with 
reference soluti on, corresponding in s ize and color.
Below Fig. 2 shows the c i rcuit test solutions 
chromatogram from tablets «Aeri us», tablets « De s lor»,
o  o  o  <o
tablets tablets tablets PhSS
<Aerius> <Deslor> <Aeriallerg> deslor.
Fi g. 2. Scheme of chromatogram from the solut i on o f t a b lets 
«Aer i us», ta b le ts  «Deslor», ta b le ts  «Aeri a lle rg»  and 
Pharmacopoe ial standard sample SPU of desloratad i ne in 
term s of ident if i ca t i on of desloratadi ne des loratad i ne 
(developer -  Dragendorff reagent).
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tablets «Аегі allerg» and Pharmacopoeial standard 
sample S PU o f d e s loratadine in terms o f і dent ificati on 
of desloratadine.
We previ ously stud ied the behav ior of placebo 
tablets i n terms o f methods o f identifi cati on o f d e s lora­
tadine. It was establ ished that the exc ip i ents are part 
of p i lls and do not affect the sens itivity and spec ifi c ity 
of desloratadine detecti on. According to the S PU a nd 
Note for gui dance on val i dati on of analytical proce­
dures: text and methodology (CPMP/ICH/381/95) to 
test the «Identifi cat ion» m ust be val i dated, to determ ine 
such characteri sti cs a s spec ifi c ity a nd suitab i l ity o f t he 
chromatograph i c system.
To investi gate the spec ifi c ity, it i s necessary to 
confi rm the selected mobi l ity o f d e sloratadine system 
to ensure proper Rf stab il ity of soluti ons in ti me. The 
maxi mum difference of Rf values i n the same plate 
(for two seri es o f p lates) m ust not e xceed the value o f
O. 02. Ori g i nally, plates were tested according to the 
requ irements of SPU o n chromatograph i c resolut i on.
When checking for the stabi l ity of the soluti on at 
the ti me we started chromatography of d esloratadine 
freshly prepared test soluti on susta i ned, over ti me for 
30 m in. Visual assessment of spots on the size and 
intens ity of sta i n ing confi rms that they clearly appear 
as freshly cooked a nd seasoned in ti me soluti ons (for 
plates of different seri es). The solutions were stable 
over ti me and new areas, had been i dentifi ed.
Thus, we explored the val i dati on characteristi cs - 
spec ific ity a nd su itab il ity o f the chromatograph ic system
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